Immunotherapy, which is currently one of the hottest fields of cancer research, is built on precision medicine. Immunotherapy is a novel technique of identifying and controlling diseases such as cancer by harnessing the potential of our immune systems. Immunotherapy is being researched in almost all types of cancer. Precision immunotherapy aims to address the essential issue of tumor-specific targeting, ensuring that the immune system's efficacy is aimed solely at cancer cells with little collateral damage to healthy cells. Precision immunotherapy's aspirational goal is to be able to properly forecast a patient's best response to highly tailored, personalized immunotherapies guided by biomarkers, such as phenotypic, genotypic, proteomic, cellular, or metabolic biomarkers.
Precision psychiatry is a new discipline within precision medicine that strives to discover and harness individual differences in biology, lifestyle, environment, and social determinants of health to enhance mental health prevention, diagnosis, and treatment. Neuropsychiatric diseases are becoming recognized as affecting people from all walks of life and causing a huge amount of pain, impairment, and even death. The next stage in realizing the potential of precision psychiatry is to include techniques from machine learning guided trials for tailored therapies, resulting in a new generation of findings in psychiatry that goes beyond existing group-based approaches.
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Personalized and precision medicine (PPM) can be established as a unique healthcare model through biodesign-driven and inspired biotech, translational applications. This approach aims to ensure human healthcare, wellness, and biosafety.
Sergey Suchkov, Institute for Biotech & Global Health of RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Monitoring folds localization in ultra-thin transition metal dichalcogenides using optical harmonic generation
Ahmed Raza Khan, Australian National University, Australia
Title : A systematic review of regulatory approaches for Direct- To- Consumers (DTC) genetic testing
Kavitha Palaniappan, Duke-NUS Medical School, Singapore
Title : Regulatory framework of in vitro diagnostic and artificial intelligence for precision medicine
Pei Ting Sarah Chou, Regulatory Affairs Professionals Society, Taiwan
Title : Unraveling cancer stem cell signatures in circulating tumor cells of metastatic colorectal cancer: Investigating ALDH1A1 and the repurposing potential of disulfiram via scRNA-seq
Nurul Syakima Ab Mutalib, Universiti Kebangsaan Malaysia, Malaysia